Latest news
19.02.2020
DEINOVE expands its range of cosmetic active ingredients
Its second innovative carotenoid has the particularity of absorbing blue light, which is responsible for premature skin ageing, the...
06.02.2020
Sharon Laboratories capitalizes on Deinove to sustain its development activities
The signed Memorandum of Understanding (MoU) covers the development and marketing of an exclusive range of bio-based ingredients for...
27.01.2020
Enrolment of first patient in Phase II trial testing DNV3837 in Clostridioides difficile infections
The Phase II clinical trial aims to evaluate the efficacy, safety and pharmacokinetics of DNV3837 in patients with Clostridioides difficile...
Press Coverage
19.06.2019
DEINOVE among The Top 20 Industrial Biotechnology Companies in Europe
Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here...
14.06.2019
Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients
La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...
05.06.2019
Zone Bourse | DEINOVE : LCM confirme sa recommandation d'Achat
LCM a confirmé sa recommandation d'Achat et son objectif de cours de 2,7 euros sur Deinove après la signature d'un partenariat avec Dow...